Cian Murphy
Impact in
-
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 7
- Oncology 8
- COVID-19 and healthcare impacts 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Vincent Plagnol (2 shared papers)Uwe Wolfrum B (1 shared paper)Christina F. Chakarova (1 shared paper)Graham E. Holder (1 shared paper)Eva Lenassi (1 shared paper)Anthony T. Moore (1 shared paper)Gavin Arno (2 shared papers)Andrew R. Webster (2 shared papers)
- Journals
- Nature Genetics (3 papers)The Lancet Oncology (2 papers)Cell (2 papers)PLoS ONE (2 papers)International Journal of Infectious Diseases (1 paper)
- Partner nations
- United KingdomSpainItaly
In The Last Decade
Cian Murphy
24 papers receiving 507 citations
Cian Murphy's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 99
- Cancer Research 54
- Cardiology and Cardiovascular Medicine 91
- Infectious Diseases 58
- Genetics 67
Countries citing papers authored by Cian Murphy
This map shows the geographic impact of Cian Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cian Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cian Murphy more than expected).
Fields of papers citing papers by Cian Murphy
This network shows the impact of papers produced by Cian Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cian Murphy. The network helps show where Cian Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Cian Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 73 | |
| 2 | 2014 | 69 | |
| 3 | 2022 | 67 | |
| 4 | Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma Hit paper breakdown → | 2025 | 65 |
| 5 | 2017 | 37 | |
| 6 | 2015 | 29 | |
| 7 | 2022 | 28 | |
| 8 | 2024 | 27 | |
| 9 | 2023 | 25 | |
| 10 | 2016 | 24 | |
| 11 | 2022 | 17 | |
| 12 | 2025 | 15 | |
| 13 | 2025 | 10 | |
| 14 | 2025 | 9 | |
| 15 | 2020 | 7 | |
| 16 | 2025 | 5 | |
| 17 | 2025 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2015 | 2 | |
| 20 | 2023 | 2 |
About Cian Murphy
Cian Murphy is a scholar working on Cancer Research, Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine and Neurology, having authored 25 papers that have together received 522 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), COVID-19 and healthcare impacts (4 papers), COVID-19 Clinical Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Genomics and Rare Diseases (3 papers), Long-Term Effects of COVID-19 (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Oncology (99 citations), Cancer Research (54 citations), Cardiology and Cardiovascular Medicine (91 citations), Infectious Diseases (58 citations) and Genetics (67 citations). Cian Murphy has collaborated with scholars based in United Kingdom, Spain and Italy. Frequent co-authors include Vincent Plagnol, Uwe Wolfrum B, Christina F. Chakarova, Graham E. Holder, Eva Lenassi, Anthony T. Moore, Gavin Arno, Andrew R. Webster, Monkol Lek and Panagiotis I. Sergouniotis. Their work appears in journals such as Nature Genetics, The Lancet Oncology, Cell, PLoS ONE and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.